Roth MKM Upgrades Orthofix Medical to Buy, Raises Price Target to $20
Portfolio Pulse from Benzinga Newsdesk
Roth MKM analyst Jason Wittes upgraded Orthofix Medical (OFIX) from Neutral to Buy and increased the price target from $15 to $20.
May 08, 2024 | 9:50 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Orthofix Medical was upgraded by Roth MKM from Neutral to Buy with a price target increase from $15 to $20.
Upgrades by analysts, especially with a significant increase in price target, typically lead to positive short-term price movements as they reflect a positive change in the analyst's view on the company's future performance and valuation.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100